ArticleAlzheimer's & dementia (New York, N. Y.)

Population pharmacokinetics of remlifanserin (ACP-204), a serotonin 2A receptor inverse agonist.

Mona Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.